Literature DB >> 29607933

Reduction of Membrane Protein CRIM1 Decreases E-Cadherin and Increases Claudin-1 and MMPs, Enhancing the Migration and Invasion of Renal Carcinoma Cells.

Nobutaka Ogasawara1, Tamami Kudo1, Masaki Sato1, Yasushi Kawasaki1, Sei Yonezawa1, Satoru Takahashi2, Yohei Miyagi3, Yasuhiro Natori1, Akinori Sugiyama1.   

Abstract

CRIM1 is a membrane protein that has been reported to be related to cell proliferation. CRIM1 is expressed in renal carcinoma cells, but its involvement in proliferation and malignant transformation remains unclear. We analyzed whether alterations in the characteristics of cancer cells are observed following knockdown of CRIM1. Decreased expression of CRIM1 did not affect proliferation or anchorage-independent growth. The results of wound healing and invasion assays showed that reduced expression of CRIM1 increased cells' migratory and invasive abilities. Expression analysis of factors involved in migration and invasion in CRIM1-knockdown cells revealed that expression of the cell adhesion factor E-cadherin declined and expression of claudin-1, which is upregulated in metastatic cancer cells, increased. In addition, increased expression of matrix metalloproteinase (MMP) 2 and MMP9, protease essential for cancer cell invasiveness, was observed. Furthermore, an increase in phosphorylated focal adhesion kinase (FAK), which increases cell migration, was observed. Increased expression of the E-cadherin transcription repressors Snail, Slug, and ZEB-1 were observed, and mRNA levels of E-cadherin were decreased. Therefore, expression of E-cadherin is thought to be decreased by both suppression of E-cadherin mRNA expression and promotion of degradation of the E-cadherin protein. In addition, expression of CRIM1 was decreased in renal cancer cells undergoing epithelial-mesenchymal transition (EMT) stimulated by tumor necrosis factor alpha (TNF-α). Thus, CRIM1 regulates the expression of several EMT-related factors and appears to play a role in suppressing migration and invasion through control of EMT.

Entities:  

Keywords:  CRIM1; E-cadherin; claudin-1; epithelial–mesenchymal transition; tumor necrosis factor alpha

Mesh:

Substances:

Year:  2018        PMID: 29607933     DOI: 10.1248/bpb.b17-00990

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  12 in total

1.  miR-335 targets CRIM1 to promote the proliferation and inhibit the apoptosis of placental trophoblast cells in preeclamptic rats.

Authors:  Liuyan Jiang; Meiyan Li; Haisi Gan; Li Yang; Fengjuan Lin; Min Hu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.

Authors:  Xiaomeng Zhang; Lie Yang; Pacman Szeto; Gamze Kuser Abali; Youfang Zhang; Aishwarya Kulkarni; Kaushalya Amarasinghe; Jason Li; Ismael A Vergara; Ramyar Molania; Anthony T Papenfuss; Catriona McLean; Mark Shackleton; Kieran F Harvey
Journal:  Oncogene       Date:  2020-06-19       Impact factor: 9.867

Review 3.  Functions of the bone morphogenetic protein signaling pathway through non-coding RNAs.

Authors:  Ural Mukhametov; Sergey Lyulin; Dmitry Borzunov; Galina Sufianova; Alina Shumadalova; Daming Zhang; Ilgiz Gareev
Journal:  Noncoding RNA Res       Date:  2022-07-09

4.  Sulforaphane metabolites inhibit migration and invasion via microtubule-mediated Claudins dysfunction or inhibition of autolysosome formation in human non-small cell lung cancer cells.

Authors:  Zhongnan Zheng; Kai Lin; Yabin Hu; Yan Zhou; Xiaoyan Ding; Yalin Wang; Wei Wu
Journal:  Cell Death Dis       Date:  2019-03-15       Impact factor: 8.469

5.  miR-665 Suppresses the Epithelial-Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1.

Authors:  Kun-Zhe Wu; Chun-Dong Zhang; Cheng Zhang; Jun-Peng Pei; Dong-Qiu Dai
Journal:  Cancer Manag Res       Date:  2020-05-15       Impact factor: 3.989

6.  miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling.

Authors:  Hu Han; Yan Li; Wan Qin; Lu Wang; Han Yin; Beibei Su; Xianglin Yuan
Journal:  Cancer Cell Int       Date:  2022-01-28       Impact factor: 5.722

7.  Expression and Prognostic Significance of Cadherin 4 (CDH4) in Renal Cell Carcinoma.

Authors:  Xiaohui Zhou; Huimei Huang; Wanmeng Cui; Yifang Wang; Wenqi Luo; Liudmila Matskova; Xiaoying Zhou
Journal:  Med Sci Monit       Date:  2020-06-08

8.  E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer.

Authors:  Tania Rossi; Gianluca Tedaldi; Elisabetta Petracci; Raefa Abou Khouzam; Guglielmina Nadia Ranzani; Paolo Morgagni; Luca Saragoni; Manlio Monti; Daniele Calistri; Paola Ulivi; Chiara Molinari
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

9.  Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU.

Authors:  Tangshun Wang; Xiang Gao; Kexin Zhou; Tao Jiang; Shuang Gao; Pengzhou Liu; Ximeng Zuo; Xiaoguang Shi
Journal:  Int J Mol Med       Date:  2020-09-15       Impact factor: 4.101

10.  Integrating transcriptome-wide association study and mRNA expression profile identified candidate genes related to hand osteoarthritis.

Authors:  Jiawen Xu; Yi Zeng; Haibo Si; Yuan Liu; Mingyang Li; Junfeng Zeng; Bin Shen
Journal:  Arthritis Res Ther       Date:  2021-03-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.